| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |